Recent Patents on CNS Drug Discovery (Discontinued)
Title:Editorial
Volume: 10 Issue: 1
Author(s): Vincenzo Di Marzo
Affiliation:
Export Options
About this article
Cite this article as:
Di Marzo Vincenzo, Editorial, Recent Patents on CNS Drug Discovery (Discontinued) 2015; 10 (1) . https://dx.doi.org/10.2174/157488981001150727102213
DOI https://dx.doi.org/10.2174/157488981001150727102213 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
26
Related Articles
-
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
Current Neuropharmacology Attempted Cell Cycle Induction in Post-Mitotic Neurons Occurs in Early and Late Apoptotic Programs Through Rb, E2F1, and Caspase 3
Current Neurovascular Research Obesity: Genetics, Behavior or a Combination of Both
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Mesenchymal Stem Cells: Key Actors in Tumor Niche
Current Stem Cell Research & Therapy Patented Herbal Formulations and their Therapeutic Applications
Recent Patents on Drug Delivery & Formulation Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Current Cancer Therapy Reviews Neurostimulation in Clinical and Sub-clinical Eating Disorders: A Systematic Update of the Literature
Current Neuropharmacology Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
Current Pharmaceutical Biotechnology Genome-Scale Technologies Foster Advances in Neurological and Behavioral Research
Current Psychiatry Reviews 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Effects of Antipsychotics on the BDNF in Schizophrenia
Current Medicinal Chemistry Galanthamine, a Natural Product for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Minocycline Inhibits mTOR Signaling Activation and Alleviates Behavioral Deficits in the Wistar Rats with Acute Ischemia stroke
CNS & Neurological Disorders - Drug Targets Specific Therapy Based on the Genotype and Cellular Mechanism in Inherited Cardiac Arrhythmias. Long QT Syndrome and Brugada Syndrome
Current Pharmaceutical Design Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Current Topics in Medicinal Chemistry Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants
Infectious Disorders - Drug Targets Editorial [Hot Topic: De-risking the Discovery and Development of New Drugs from Bench to Clinic (Guest Editor: Sergey Ilyin)]
Current Topics in Medicinal Chemistry Alkylglycerol Lipid Precursors: A Review of Therapeutic Strategies for Plasmalogen Replacement
Current Organic Chemistry